SPE Capital Partners announces final close of North Africa-focused fund

SPE Capital Partners has announced the final close of SPE AIF I, its $200M North Africa-focused private equity fund. 

SPE AIF I was launched in 2019 to invest in companies across Africa, with a particular focus on North Africa. The fund strategy includes majority transactions in companies with growth potential, operating in sectors such as industrial goods, services, healthcare, and education.


Discover all investors and enablers on the MAGNiTT platform


Nabil Triki, Managing Partner and CEO at SPE Capital commented, “This is a significant milestone for our young firm. We are grateful for the strong vote of confidence from our investors, whose unwavering support has been invaluable. The challenging environment we’re currently in underlines the importance of investing in resilient sectors and high-quality companies.”

To date, SPE AIF I has invested in 4 companies: 1. Future Pharmaceutical Industries, a rapidly growing branded generics manufacturer in Egypt 2. Holged Tunisie, the private K-12 school operator in Tunisia 3. Dislog Group, a premier FMCG producer and distributor in Morocco 4. Amanys Pharma (formerly Saham Pharma), an antibiotics manufacturer and injectables distributer in Morocco.

With offices across the region, SPE Capital is an independent private equity firm focused on Africa and the Middle East. SPE Capital is led by an on-the-ground investment team, with local knowledge and a track record of investing in growth companies. 


Are you a startup looking for investment? Apply for funding to 110+ investors now.